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Background and Purpose—We determined prevalences of neurological complications, vascular abnormality, and infarction 
in Tanzanian children with sickle cell disease.
Methods—Children with sickle cell disease were consecutively enrolled for transcranial Doppler; those with slightly elevated 
(>150 cm/s), low (<50 cm/s) or absent cerebral blood flow velocity (CBFv) were invited for brain magnetic resonance 
imaging and magnetic resonance angiography.
Results—Of 200 children (median age 9; range 6–13 years; 105 [2.5%] boys), 21 (11%) and 15 (8%) had previous seizures 
and unilateral weakness, respectively. Twenty-eight (14%) had elevated and 39 (20%) had low/absent CBFv, all associated 
with lower hemoglobin level, but not higher indirect bilirubin level. On multivariable analysis, CBFv>150 cm/s was 
associated with frequent painful crises and low hemoglobin level. Absent/low CBFv was associated with low hemoglobin 
level and history of unilateral weakness. In 49 out of 67 children with low/absent/elevated transcranial Doppler undergoing 
magnetic resonance imaging, 43% had infarction, whereas 24 out of 48 (50%) magnetic resonance angiographies were 
abnormal. One had hemorrhagic infarction; none had microbleeds. Posterior circulation infarcts occurred in 14%. Of 11 
children with previous seizure undergoing magnetic resonance imaging, 10 (91%) had infarction (5 silent) compared with 
11 out of 38 (29%) of the remainder (P=0.003). Of 7 children with clinical stroke, 2 had recurrent stroke and 3 died; 4 out 
of 5 had absent CBFv. Of 193 without stroke, 1 died and 1 had a stroke; both had absent CBFv.
Conclusions—In one-third of Tanzanian children with sickle cell disease, CBFv is outside the normal range, associated with 
frequent painful crises and low hemoglobin level, but not hemolysis. Half have abnormal magnetic resonance angiography. 
African children with sickle cell disease should be evaluated with transcranial Doppler; those with low/absent/elevated 
CBFv should undergo magnetic resonance imaging/magnetic resonance angiography.   (Stroke. 2019;50:1719-1726. 
DOI: 10.1161/STROKEAHA.118.018920.)
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Although there are few data available from sub-Saharan Africa, stroke and silent cerebral infarcts (SCI) detected 
by magnetic resonance imaging (MRI) are common in un-
treated sickle cell disease (SCD) elsewhere.1,2 Arterial is-
chemic stroke in the territories of the middle and anterior 
cerebral arteries and their border zones is typical.3,4 Posterior 
reversible encephalopathy syndrome has been reported5 and 
is not always reversible although residual occipital or cere-
bellar infarction is rarely reported in cross-sectional studies. 
Hemorrhagic stroke occurs in the context of hypertension6 and 
aneurysm formation,7 but the prevalence of microbleeds re-
mains uncertain.
Magnetic resonance angiography (MRA) detects intra-
cranial arteriopathy.8 Stenosis or occlusion of the intracranial 
arteries may be detected with transcranial Doppler (TCD), 
measuring cerebral blood flow velocity (CBFv); abnormal 
internal carotid artery (ICA)/middle cerebral artery (MCA) 
CBFv (>200 cm/s) occurs in 2.8% to 10% of children9,10 and 
predicts clinical stroke.11 Low anterior cerebral artery and 
MCA CBFv may also predict stroke and SCI,12 but there is an 
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overlap with those with inadequate TCD;10 there are few data 
comparing TCD with MRA in this group.
Data from Africa on the prevalence in SCD of TCD out-
side the normal range (50–149 cm/s)13 are scarce, although 
conditional (>170 and ≤200 cm/s) and abnormal CBFv (>200 
cm/s) have been reported in 4% and 7%, respectively14; there 
seems to be considerable variability. Of 105 Kenyan children, 
only 3% had conditional, and none had abnormal CBFv.15 A 
Nigerian study of 145 children found that 5% had CBFv >200 
cm/s and 20% had CBFv >150 cm/s,16 whereas in Cameroon, 
22% had abnormal MCA CBFv.17 MRI was not performed in 
any of these studies.
We conducted a cross-sectional study to determine the 
prevalence of elevated/absent/low CBFv in Tanzanian chil-
dren with SCD and imaged those with abnormal TCD to de-
termine whether there was an association between elevated or 
low CBFv and silent infarction or microbleeds in the anterior 
or posterior circulation on MRI or cerebrovascular disease 
on MRA.
Methods
Ethical clearance and permission to conduct this study were obtained 
from the Senate Research and Publications Committee of Muhimbili 
University of Health and Allied Sciences and Muhimbili National 
Hospital. All parents/guardians of the children gave written consent. 
The data that support the findings of this study are available from the 
corresponding author on reasonable request.
The inclusion criteria for the study were children with SCD (con-
firmed with hemoglobin electrophoresis; no hemoglobin SC disease 
in this cohort) aged between 6 and 13 years enrolled in the Muhimbili 
Sickle Cohort18 who consecutively attended the SCD outpatient clinic 
of the Muhimbili National Hospital in Dar es Salaam, Tanzania 
from June 2010 to March 2011. Penicillin was prescribed, and use 
of insecticide-treated nets was emphasized to prevent malaria infec-
tions, but chloroquine and hydroxyurea were not prescribed, and no 
child was on a chronic blood transfusion regime. A structured ques-
tionnaire was used to determine demographic characteristics, and 
clinical events and all children had a complete general and neurolog-
ical examination. We used a recall period of 2 years for admissions 
and blood transfusions and 1 year for painful crises to minimize bias. 
Blood pressure, oxygen saturation, and hemoglobin were measured 
on the day of the TCD examination when the child was well.
The basal cranial arteries (MCA, anterior cerebral artery, ICA) 
were insonated with a 2 MHz probe and nonimaging TCD (Viasys 
Health Care). All examinations were performed by 1 author (E.N. 
Kija), with Dr Newton checking the recordings outside the normal 
range. The CBFv in the MCA/ICA was classified as follows low 
(CBFv <50 cm/s), normal (50–149 cm/s),13 slightly elevated (150–
169 cm/s), conditional (170–199 cm/s), and abnormal (CBFv≥200 
cm/s).11 Children who had a TCD exam outside the normal range (no 
signal, CBFv <50 cm/s, or CBFv >150 cm/s) were scheduled to have 
brain MRI/MRA brain (Figure I in the online-only Data Supplement).
MRI scanning was performed on a Phillips Achieva 1.5 Tesla 
MRI scanner, using an 8-channel head coil, at a median duration of 5 
months (range 3–7 months) after the TCD examination. The scanning 
protocol included T1-weighted spin echo (repetition time [TR]/echo 
time [TE]/flip angle=596 ms/15 ms/69°), T2-weighted fast spin echo 
(TR/TE/flip angle=4424 ms/100 ms/90°), T2* weighted gradient 
echo (T2*gradient echo; TR/TE/flip angle=700 ms/23 ms/18°), fluid-
attenuated inversion recovery (TR/TE/TI/flip angle=11 000 ms/140 
ms/2800 ms/90°), diffusion-weighted imaging (b=0, 500, 1000 s/
mm2) and susceptibility weighted imaging (TR/TE/flip angle=35 
ms/50 ms/15°), all acquired in the axial plane, and 3D time-of-flight 
MRA (TR/TE/flip angle=35 ms/5 ms/20° and 0.7 mm slice thickness).
T2-weighted, fluid-attenuated inversion recovery and diffusion-
weighted imaging images were used to determine the presence of 
infarcts and atrophy. Images were reviewed independently by 3 neu-
roradiologists (D.E. Saunders, S. Barker, T.C.S. Cox); where there 
was disagreement, the scans were reviewed by Dr Saunders, and con-
sensus was achieved when 2 neuroradiologists agreed.
SCI was defined as ≥1 focal MRI signal abnormalities of at least 
3 mm in 1 dimension visible in 2 views on fluid-attenuated inversion 
recovery/T2-weighted images in the absence of a focal neurological 
deficit.2 T2*gradient echo and susceptibility weighted imaging were 
inspected for hemorrhage. MRA maximum intensity projections 
were used to determine the presence of intracranial artery abnor-
mality using a previously reported grading system.18
Children were followed until censoring at stroke or death or 
March 31, 2014.
The data were analyzed in SPSS v22. Skewed data were summa-
rized with median and interquartile range. Association between vari-
ables was determined using χ2 test and Fisher exact tests. Univariable 
and multivariable logistic regression were used to determine clinical 
predictors of elevated/absent/low CBFv. Mann-Whitney and Kruskal-
Wallis tests were used to compare the distribution of variables be-
tween 2 and >2 variables, respectively. Interobserver variability 
between the neuroradiologists was analyzed using the method of 
Fleiss with the web-based programme of Geertzen (https://mlnl.net/
jg/software/ira/). A P<0.05 was considered as statistically significant.
Results
From June 2010 to March 2011, 200 consecutive children 
(median age, 9; range, 6–13 years; 105 (52.5%) boys) meeting 
the inclusion criteria were enrolled. Fifteen (8%) had a history 
of unilateral weakness, and 21 (11%) had a history of seizures 
(Table 1). TCD examination was outside the normal range in 
67 (34%) children, of whom 28 (14%) had elevated CBFv 
>150 cm/s and 39 (20%) had CBFv<50 cm/s (n=10) or absent 
signal (n=29; Table 1). Sixteen had slightly elevated CBFV 
(150–169 cm/s), 11 (5.5%) had conditional CBFv (170–199 
cm/s), but only one, who had already had a clinical stroke, 
had an abnormal high CBFv (>200 cm/s). Elevated CBFv was 
more common in children aged <12 years old. Hemoglobin 
was lower in those with low/absent and elevated CBFv, but 
there was no association with indirect bilirubin as a marker of 
hemolysis (Table 1).
Risk Factors for Low CBFv or Absent MCA Signal
Compared with those with normal velocities, children with 
absent/low CBFv or MCA signal were more likely to have a 
history of focal weakness and seizures (Table 2). In multivari-
able analysis, low hemoglobin and history of focal weakness 
were independent predictors of absent/low CBFv (Table 2).
Risk Factors for Elevated CBFv
Compared with children with normal CBFv, those with ele-
vated CBFv >150 cm/s in the MCA were more likely to have 
a history of seizures, but not focal weakness. They also had 
more frequent painful crises in the previous 2 years compared 
with those with normal CBFv (Table 1). In multivariable anal-
ysis, low hemoglobin and frequent painful crises were inde-
pendent predictors of elevated CBFv (Table 2).
Patients Who Had MRI Scans
Of the 67 children with TCD examinations outside the normal 
range, 18 (27%) did not return for MRI (Figure I in the online-
only Data Supplement). There was no difference in the dem-
ographic or clinical features of those children who did not 
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return for the scans compared with those who did (Table I 
in the online-only Data Supplement). For documentation of 
infarction among the 3 observers, κ was 0.629 (good agree-
ment); whereas for determination of normal MRA and definite 
MRA abnormality, κ was 0.849 (excellent agreement).
Of the 49 children who had MRI, 21 (43%) had abnormal 
scans (Figures 1 and 2; Figures II and III in the online-only 
Data Supplement), that is, at least 21 out of 200 (11%) of the 
overall sample. Most infarcts occurred in the anterior circula-
tion, in deep white matter and basal ganglia (Table 3), but 7 
(14%) had occipital or cerebellar infarcts or atrophy (Table 3, 
Figure 1). All but one had large vessel disease, mostly involv-
ing the terminal cavernous and carotid arteries; in 2, the pos-
terior circulation infarction was associated with generalised 
disease. Seven patients had had clinical stroke (14% of those 
undergoing MRI, 4% of the total and 70% of those with a 
history of focal weakness). SCI occurred in 14 (29% of those 
undergoing MRI or at least 7% of the overall sample). SCI 
was present in 8 out of 21 (38%) of the children who had 
CBFv >150 cm/s, and in 6 out of 24 (25%) of the children 
with absent signal, but there were no SCI in the 4 with low 
CBFv. One patient with slightly elevated CBFv had hemor-
rhage associated with basal ganglia infarction (Figure 2), but 
no microbleeds were detected on T2*gradient echo or suscep-
tibility weighted imaging.
Twenty-four patients with TCD outside the normal range 
had abnormal MRA (Figures 1 and 2; Figures II and III in 
the online-only Data Supplement; Table 4), 50% of the 48 
scanned (1/49 with clinical stroke and abnormal CBFv>200 
cm/s failed MRA). This represents at least 36% of the 67 with 
elevated/low CBFv, and the majority had stenosis/occlusion 
(grades 2/3).18 One patient had moyamoya (grade 4;18 Figure 
II in the online-only Data Supplement). Turbulence without 
definite narrowing or occlusion (grade 1;18 Figure III in the 
Table 1. Patient Characteristics by CBFv Category
Variables Normal CBFv Low CBFv/No Signal Elevated CBFv*
 No % No % P Value† No % P Value†
Age group, y
  6–8 54 40.6 17 43.6 0.565 13 46.4 0.053
  9–11 48 36.1 16 41.0  14 50.0  
  12+ 31 23.3 6 15.4  1 3.6  
Sex
  Male 70 52.6 20 51.3 0.882 15 53.6 0.928
  Female 63 47.4 19 48.7  13 46.4  
History of admissions
  No admission 54 40.6 15 38.5 0.488 14 50.0 0.138
  2–3 59 44.4 15 38.5  7 25.0  
  >3 20 15.0 9 23.0  7 25.0  
History of blood transfusions
  No blood transfusion 47 35.3 11 28.2 0.407 12 42.9 0.453
  Blood transfusion 86 66.7 28 71.8  16 57.1  
History of seizures
  Yes 8 6.0 8 20.5 0.011 5 17.9 0.052
  No 125 94.0 31 79.5  23 82.1  
History of weakness
  Yes 4 3 8 20.5 0.001 3 10.7 0.102
  No 129 97 31 79.5  25 89.3  
Number of painful crises in past 2 y
  Median (IQR) 3 (1–5) 3 (1–6) 0.718 6 (3–10) 0.002
Laboratory values
  Hemoglobin, g/dL mean±SD 7.5±1.2 7.0±1.6 0.025 6.8±0.9 0.003
  Oxygen saturation, %, median (range) 98 (96,99) 98 (97,100) 0.201 98 (97,100) 0.321
  Indirect bilirubin, μmol/L, median (IQR) 31.7 (16.4–54.5) 31.4 (20.9–55.5) 0.655 37.3 (22.9–60.2) 0.441
CBFv indicates cerebral blood flow velocity; and IQR, interquartile range.
*Elevated includes slightly elevated (CBFv 150–169 cm/s), conditional (CBFv 170–199 cm/s) and abnormal (CBFv >200 cm/s).
†For comparison with normal.
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online-only Data Supplement) was not counted as abnormal. 
MRA was more likely to be abnormal in those with infarction 
on MRI (χ2=12.34; P=0.00044). Of the 6 out of 7 children with 
clinical stroke who had MRA, all were abnormal, whereas of 
the 14 children with SCI who also had MRA, 10 (71%) were 
abnormal. Abnormal MRA was documented in 8 out of 24 
with absent TCD signal (33%), 1 out of 4 with CBFV<50 cm/s 
(25%) and 9 out of 20 (45%) with CBFV>150 cm/s.
Although abnormal ICA/MCA velocity (>200 cm/s) was 
rare in this cohort, absent or low velocities were common in 
those with previous clinical presentations and those with ab-
normal MRA (Table II in the online-only Data Supplement). 
Of the 7 with clinical stroke, 2 had elevated and 5 had absent 
CBFv. Of the 14 with SCI, 8 had elevated CBFv and 6 had ab-
sent CBFv. Three patients died, 2 of whom had prior strokes 
with absent CBFv and 1 with absent CBFv and normal MRI 
who died during an episode of severe anemia. Four children 
had a subsequent stroke, 1 with absent CBFv and SCI and 
3 with previous stroke (2 with elevated CBFv, 1 with absent 
CBFv). The remaining 13 children with SCI did not experi-
ence subsequent strokes and, although 2 of the 11 with con-
ditional TCD and the 1 child with abnormal TCD had had 
previous neurological symptoms, these 10 children did not 
experience stroke during follow-up.
Of 11 children with a history of seizures undergoing MRI, 
10 (91%) had infarction (5 silent) compared with 11 out of 38 
(29%; 10 silent) of those with no history of seizures (Fisher 
exact test P=0.0003); 7 out of 10 also had MRA abnormality 
compared with 17 out of 38 of those without seizures (Fisher 
exact test P=0.14). Seven of 9 children (78%) with a history of 
contralateral weakness had stenosis or occlusion of the basal 
cranial arteries on MRA compared with 17 out of 39 (44%) of 
those without weakness (P=0.137).
Discussion
More than a third of Tanzanian children with SCD had TCD 
recordings outside the normal range (<50 or >150 cm/s), con-
sistent with cerebrovascular disease or, for those with elevated 
CBFv, cerebral hyperemia. Although 12 (6%) had CBFv>170 
cm/s, only one patient (0.5%) had abnormally high CBFv>200 
cm/s. Frequent painful crises in the previous year and lower 
hemoglobin was associated with a CBFv>150 cm/s. Low he-
moglobin and focal neurological deficits were associated with 
low/absent velocities. The proportion of children with ele-
vated, low, or absent CBFv who had infarction on MRI was 
43%, with SCI comprising 31% of this selected group.
The prevalence of TCD outside the normal range was sim-
ilar to most of the previous studies in Africa.14–17 The lower 
proportion of abnormal high CBFv (>200 cm/s) may be be-
cause of rapid progression of the disease in Africa, with pro-
gressive stenosis of internal carotid and MCAs leading to 
occlusion with lower CBFv distally, consistent with our find-
ing of a high prevalence of absent/CBFv, particularly in those 
with clinical presentations. The high mortality for the children 
with clinical stroke undergoing MRI (2/7) is consistent with 
the possibility that those with progressive cerebrovascular 
disease died at a younger age; African survival cohorts may, 
therefore, seem to have less severe CVD. We documented ste-
nosis and occlusion on MRA, although only one child had 
moyamoya collaterals. MRA of the neck might reveal addi-
tional stenosis or occlusion.19
The prevalence of focal weakness was similar to studies of 
stroke from the pre-TCD screening era in North America,1 and 
the prevalence of seizures is similar to data from Nigeria,20 
although a little higher than in the Jamaican cohort.21 As the 
patients with elevated/low/absent CBFv were selected for 
MRI, the minimum prevalence of SCI of 7% is likely to be 
an underestimate. Although there is a previously documented 
Table 2. Risk factors for No Signal/Low CBFv and Elevated CBFv
Univariable Analysis Multivariable Analysis
Variable OR 95% CI P Value OR 95% CI P Value
No signal/low CBFv
  History of seizures
   Yes 3.53 1.16–10.57 0.023 2.37 0.71–7.78 0.153
  History of weakness
   Yes 7.28 2.07–29.28 0.003 5.64 1.50–23.54 0.011
  No of painful crises in past 2 y 1.04 0.95–1.13 0.279 … … …
Hemoglobin level, g/dL 0.73 0.54–0.98 0.038 0.74 0.53–1.00 0.051
Elevated CBFv
  Seizures
   Yes 3.40 0.96–11.14 0.046 1.83 0.39–7.34 0.409
  History of weakness
   Yes 5.38 1.20–24.18 0.023 2.73 0.46–14.78 0.242
  No of painful crises in past 2 y 1.14 1.05–1.26 0.003 1.13 1.03–1.25 0.009
  Hemoglobin level, g/dL 0.55 0.35–0.81 0.004 0.59 0.37–0.90 0.020
CBFv indicates cerebral blood flow velocity; and OR, odds ratio.
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association between abnormal high CBFv >200 cm/s and 
SCI, most with SCI have normal TCD.22 Our observed SCI 
prevalence in midchildhood (at least 7% of the total popula-
tion and 29% of those scanned for elevated/low/absent CBFv), 
seems lower than that in unselected populations elsewhere.2 
A larger study of unselected patients will be required to de-
termine whether this holds for those with CBFv within the 
normal range, as well as those with elevated or low CBFv. 
This is important as 1 study found that children with normal 
TCD velocities and no SCI had a lower rate of neurological 
events compared with those with SCI and a normal TCD.23 
This is a survival cohort with high prevalence of alpha thalas-
semia14 and Central African Republic haplotypes, which are 
associated with reduced risk of stroke, so it is biologically 
plausible that SCI is less common.
The distribution of infarction in the basal ganglia and deep 
white matter is similar to that reported in other studies,24 but we 
also report occipital and cerebellar infarction typical of a poste-
rior circulation distribution; the anterior cerebrovascular disease 
associated may reflect the severity of disease in untreated chil-
dren with SCD. The absence of corresponding posterior large 
vessel disease in children with posterior circulation infarcts 
may reflect the lack of imaging of the vertebrobasilar system in 
this cohort but also raises the possibility of an alternative cause, 
such as poor oxygen delivery or cardiac embolic source.
Interestingly, abnormal MRA was documented in more 
than half of the children with CBFv>150 cm/s, including 8 
out of 11 with CBFv 150–169 cm/s as well as 4 of 9 with 
conditional TCD (the child with abnormal TCD failed MRA). 
Figure 1. Ten-y-old Tanzanian girl with seizures and focal weakness with ab-
sent transcranial Doppler velocities. A, Axial T2-weighted magnetic resonance 
image showing mature right MCA (middle cerebral artery)/PCA (posterior ce-
rebral artery) watershed territory (black arrow) and left MCA territory infarcts. 
Bilateral deep gray and deep white matter watershed lesions are seen bilater-
ally. B, A small left cerebellar infarct (white arrow) is seen in the same patient. 
C, The magnetic resonance angiogram reveals an occluded left MCA (short 
arrow) and a narrow right MCA (long arrow). The PCAs appear normal. Mar-
row expansion of the skull vault is noted. The patient subsequently died. 
Table 3. MRI Findings in 49 Children With Abnormal TCD
Finding
No. of 
Patients %
Any abnormality 21 43
Generalized atrophy 5 10
Infarction 21 43
 Unilateral 4 8
 Bilateral 17 35
Focal arterial infarction
  Anterior circulation 4 8
   ACA 0 0
   MCA 3 6
   Both ACA and MCA 1 2
  Posterior circulation 7 14
   Occipital 4 8
   Cerebellar 2 4
   Occipital and cerebellar 1 2
  Watershed territory infarcts
   Deep WM 21 42
   Temporal 2 4
   Basal ganglia 4 8
   Normal 28 57
Some individuals had ≥1 outcome on MRI. ACA indicates anterior cerebral 
artery, MCA, middle cerebral artery, MRI, magnetic resonance imaging; TCD, 
transcranial Doppler; and WM, white matter.
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Absent/low CBFv in the ICA/MCA may be secondary to 
extracranial stenosis or occlusion with low distal flow (not 
excluded as neck vessel imaging was not performed), as well 
as intracranial disease, demonstrated on MRA in 50% of low 
and 42% of absent TCD in this study, or to difficulties in 
obtaining signal through a thick skull.10
In our study, all of those with overt stroke, and nearly 3 quar-
ters of those with SCI, had abnormal MRA, apparently higher 
than in previous US studies. MRA abnormality was reported 
in 58% of children with clinical stroke in the SWiTCH study 
(Stroke With Transfusions Changing to Hydroxyurea),8 in 16% 
of those with SCI in the SIT trial (Silent Infarct Transfusion),22 
and in 25% of children with SCD in the STOP study (Stroke 
Prevention Trial in Sickle Cell Anemia) of children with ab-
normal CBFV>200 cm/s.25 In the Tanzanian children, the most 
common MRA abnormality found in children with elevated/low/
absent CBFv was stenosis, similar to the studies in the American 
children.25 In contrast to children with stroke, in whom MRA ab-
normality was only seen in those with absent/low CBFv,8 we also 
documented abnormal MRA in children with CBFv>150 cm/s.
Seizures were more common in children with elevated/
absent/low CBFv, consistent with previous UK data.26 In our 
study, children with elevated/low/absent CBFv and a history of 
seizure had a higher proportion of infarcts than children who did 
not have a history of seizure. The CSSCD study (Cooperative 
Study of Sickle Cell Disease) of American children also found 
that seizures were associated with stroke and SCI,27 but did not 
report TCD or MRA. Prengler et al26 found no association be-
tween abnormal MRA findings and history of seizure, although 
CBFv was higher in those with seizures. Cerebrovascular di-
sease should be excluded in children with SCD and seizures, al-
though seizures may occur early in an active pathophysiological 
process when CBFv is abnormal, but MRA is not.
Study Limitations
Some of the clinical parameters are prone to recall bias despite 
the relatively short period. Given the high mortality of children 
with SCD in Tanzania within the first 5 years of life,28 the chil-
dren with the most severe disease may have died and the data 
may not be generalizable. MRI and MRA were obtained at a 
mean of 5 months after the TCD, during which time CBFv may 
have changed. Children were recruited from outpatient clinics 
when clinically well, leading to a potential for bias in excluding 
sicker children which may account for the lack of children 
with abnormal TCD, although routine outpatients is also typ-
ically the setting for TCD screening in the North. As a result 
of their relative rarity in this cohort, it was neither possible to 
explore any differences in effect of conditional or abnormal 
CBFv compared with slightly elevated CBFv nor to determine 
whether elevated TCD was associated with abnormal MRA. 
A quarter of children with CBFv outside the normal range did 
not return for MRI, which may have introduced selection bias, 
Figure 2. A, Hemorrhagic basal ganglia infarct in a 16-y-old girl not reporting symptoms but with asymmetric  transcranial Doppler velocities (right time aver-
aged mean of the maximum 39, left 164 cm/sec). The subtle hemorrhagic change is seen as a dark blush on the T2-weighted sequence but is well seen on 
the (B) T2* sequence (white arrows). C, A magnetic resonance angiogram revealed severe stenosis of the right middle cerebral artery with reduced filling of 
the distal vessels. She was followed for 3 y and did not develop neurological symptoms.
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although there was no evidence for selection of children by age 
or with a history of neurological problems. Children with SCD 
and normal TCD examinations did not undergo MRI, whereas 
MRA of the neck was not included, so the proportions of SCI 
and MRA abnormality are minimum estimates. The prevalence 
of abnormalities may be different, but our interobserver vari-
ability for MRI reporting was good, similar to that reported 
from the SIT trial29 with the same definition2,30 and that for the 
MRA abnormalities was even better.
Conclusions
This study shows that elevated/absent/low CBFv and MRI 
abnormalities are common in children with SCD in Africa and 
that frequent painful crises in the past year and low hemo-
globin are independent risk factors for these abnormalities in 
addition to seizures and clinical stroke. TCD may be useful in 
centers in Africa that do not have access to MRI, provided that 
evidence-based treatment for Conditional or Abnormal CBFv 
is available; there is now some evidence that hydroxyurea, 
which is relatively low cost, reduces CBFv. Longitudinal stud-
ies are required to determine the outcome and neurocognitive 
functioning of children with TCD outside the normal range 
and abnormal MRI/MRA.
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